Net delta exposure for Beam Therapeutics Inc (BEAM) options was $19.4M per 1% move at the Nov 4, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 7, 2026, it was $9.39M.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for BEAM, 2026-11-20(m), calls & puts
Delta Exposure Stats
Showing results for BEAM, 2026-11-20(m), calls & puts
Net Delta Exposure by Expiration
Showing results for BEAM, 2026-11-20(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|
BEAM Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is BEAM delta exposure positive or negative?
Beam Therapeutics net delta exposure was positive on Nov 4, 2026, at $19.4M. It has been positive on 20 of the last 20 trading days.
How has BEAM delta exposure changed recently?
Beam Therapeutics net delta exposure went from $9.39M on Oct 7, 2026 to $19.4M on Nov 4, 2026. See the BEAM delta exposure history for a longer view.
What is Beam Therapeutics Inc?
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases.